Monitored Therapeutics, Inc. Press Releases

• Published on November 18, 2024 - 19:08 GMT

  Bridgeworx Partners and Monitored Therapeutics Form Alliance to Accelerate Commercialization of Respiratory Technologies

  DUBLIN, OH, UNITED STATES, November 18, 2024 /⁨EINPresswire.com⁩/ -- Bridgeworx Partners (Bridgeworx.co) and Monitored Therapeutics Inc. (MonitoredRx.com) are excited to announce a strategic alliance focused on accelerating the commercialization of …

  Distribution channels: Business & Economy, Companies ...
• Published on August 13, 2024 - 20:10 GMT

  Monitored Therapeutics Announces Revolutionary Diagnostic Tool for Primary Care

  GoClinic® Respiratory Evaluation Released DUBLIN, OH, UNITED STATES, August 13, 2024 /⁨EINPresswire.com⁩/ -- Monitored Therapeutics, Inc. (MTI), a Digital Health company focused on end-to-end respiratory solutions, is pleased to announce the release of …

  Distribution channels: Business & Economy, Companies ...
• Published on February 14, 2024 - 16:16 GMT

  Monitored Therapeutics Announces Approval of the GoSpiro® Spirometer by China’s NMPA

  Partnership Opens up Chinese Market; Increases Production Capabilities DUBLIN, OH, UNITED STATES, February 14, 2024 /⁨EINPresswire.com⁩/ -- Monitored Therapeutics, Inc. (MTI), a Remote Patient Monitoring company, is pleased to announce the approval of its …

  Distribution channels: Business & Economy, Companies ...
• Published on August 15, 2023 - 15:36 GMT

  Monitored Therapeutics Welcomes Former Cardinal Health CEO Mike Kaufmann as Chairman of the Board

  Remote Patient Monitoring Company adds Former Cardinal Health CEO DUBLIN, OH, UNITED STATES, August 15, 2023 /⁨EINPresswire.com⁩/ -- Monitored Therapeutics, Inc. (MTI), a Remote Patient Monitoring company, is thrilled to announce the appointment of Mike …

  Distribution channels: Business & Economy, Companies ...
• Published on February 14, 2022 - 10:00 GMT

  

  Monitored Therapeutics GoSpiro Spirometer Monitors Patients in Pulmotect’s Two Successful COVID- 19 Phase 2 Studies

  Remote Patient Monitoring Solution Delivers Lab-Quality Results DUBLIN, OHIO, USA, February 14, 2022 /⁨EINPresswire.com⁩/ -- Pulmotect, Inc., recently announced results from two Phase 2 clinical trials undertaken to evaluate the inhalation of its PUL-042 …

  Distribution channels: Business & Economy, Consumer Goods ...